Martin-Broto, J; Hindi, N; Lopez-Pousa, A; Peinado-Serrano, J; Alvarez, R; Alvarez-Gonzalez, A; Italiano, A; Sargos, P; Cruz-Jurado, J; Isern-Verdum, J; Dolado, MC; Rincon-Perez, I; Sanchez-Bustos, P; Gutierrez, A; Romagosa, C; Morosi, C; Grignani, G; Gatti, M; Luna, P; Alastuey, I; Redondo, A; Belinchon, B; Martinez-Serra, J; Sunyach, MP; Coindre, JM; Dei Tos, AP; Romero, J; Gronchi, A; Blay, JY; Moura, DS
Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas A Nonrandomized Phase 1/2 Clinical Trial
JAMA ONCOLOGY
Tap, WD; Wagner, AJ; Schoffski, P; Martin-Broto, J; Krarup-Hansen, A; Ganjoo, KN; Yen, CC; Razak, AAR; Spira, A; Kawai, A; Le Cesne, A; Van Tine, BA; Naito, Y; Park, SH; Fedenko, A; Papai, Z; Soldatenkova, V; Shahir, A; Mo, G; Wright, J; Jones, RL
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas The ANNOUNCE Randomized Clinical Trial
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
D'Ambrosio, L; Touati, N; Blay, JY; Grignani, G; Flippot, R; Czarnecka, AM; Piperno-Neumann, S; Martin-Broto, J; Sanfilippo, R; Katz, D; Duffaud, F; Vincenzi, B; Stark, DP; Mazzeo, F; Tuchscherer, A; Chevreau, C; Sherriff, J; Estival, A; Litiere, S; Sents, W; Ray-Coquard, I; Tolomeo, F; Le Cesne, A; Rutkowski, P; Stacchiotti, S; Kasper, B; Gelderblom, H; Gronchi, A
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
CANCER
Demetri, GD; Antonescu, CR; Bjerkehagen, B; Bovee, JVMG; Boye, K; Chacon, M; Dei Tos, AP; Desai, J; Fletcher, JA; Gelderblom, H; George, S; Gronchi, A; Haas, RL; Hindi, N; Hohenberger, P; Joensuu, H; Jones, RL; Judson, I; Kang, YK; Kawai, A; Lazar, AJ; Le Cesne, A; Maestro, R; Maki, R; Martin, J; Patel, S; Penault-Llorca, F; Raut, CP; Rutkowski, P; Safwat, A; Sbaraglia, M; Schaefer, IM; Shen, L; Serrano, C; Schoffski, P; Stacchiotti, S; Hall, KS; Tap, WD; Thomas, DM; Trent, J; Valverde, C; van der Graaf, WTA; von Mehren, M; Wagner, A; Wardelmann, E; Naito, Y; Zalcberg, J; Blay, JY
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
ANNALS OF ONCOLOGY
Radaelli, S; Fossati, P; Stacchiotti, S; Akiyama, T; Asencio, JM; Bandiera, S; Boglione, A; Boland, P; Bolle, S; Bruland, O; Brunello, A; Bruzzi, P; Campanacci, D; Cananzi, F; Capanna, R; Casadei, R; Cordoba, A; Court, C; Dei Tos, AP; DeLaney, TF; De Paoli, A; De Pas, TM; Desai, A; Di Brina, L; Donati, DM; Fabbri, N; Fiore, MR; Frezza, A; Gambarotti, M; Gasbarrini, A; Georg, P; Grignani, G; Hindi, N; Hug, EB; Jones, R; Kawai, A; Krol, AD; Le Grange, F; Luzzati, A; Marquina, G; Martin-Benlloch, JA; Mazzocco, K; Navarria, F; Navarria, P; Parchi, PD; Patel, S; Pennacchioli, E; Petrongari, MG; Picci, P; Pollock, R; Porcu, L; Quagliuolo, V; Sangalli, C; Scheipl, S; Scotto, GM; Spalek, M; Steinmeier, T; Timmermann, B; Trama, A; Uhl, M; Valverde, C; Varga, PP; Verges, R; Weber, DC; Zoccali, C; Casali, PG; Sommer, J; Gronchi, A
The sacral chordoma margin
EJSO
Martin-Broto, J; Cruz, J; Penel, N; Le Cesne, A; Hindi, N; Luna, P; Moura, DS; Bernabeu, D; de Alava, E; Lopez-Guerrero, JA; Dopazo, J; Pena-Chilet, M; Gutierrez, A; Collini, P; Karanian, M; Redondo, A; Lopez-Pousa, A; Grignani, G; Diaz-Martin, J; Marcilla, D; Fernandez-Serra, A; Gonzalez-Aguilera, C; Casali, PG; Blay, JY; Stacchiotti, S
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial
LANCET ONCOLOGY
Perez, M; Garcia-Heredia, JM; Felipe-Abrio, B; Munoz-Galvan, S; Martin-Broto, J; Carnero, A
Sarcoma stratification by combined pH2AX and MAP17 (PDZK1IP1) levels for a better outcome on doxorubicin plus olaparib treatment
SIGNAL TRANSDUCTION AND TARGETED THERAPY
Martin-Broto, J; Reichardt, P; Jones, RL; Stacchiotti, S
Different approaches to advanced soft tissue sarcomas depending on treatment line, goal of therapy and histological subtype
EXPERT REVIEW OF ANTICANCER THERAPY
Gonzalez, LMD; Martin-Broto, J; Kasper, B; Blay, JY; Le Cesne, A
Real-world evidence of the efficacy and tolerability of trabectedin in patients with advanced soft-tissue sarcoma
EXPERT REVIEW OF ANTICANCER THERAPY
Martin-Broto, J; Moura, DS
New drugs in gastrointestinal stromal tumors
CURRENT OPINION IN ONCOLOGY
Napolitano, A; Provenzano, S; Colombo, C; Vitellaro, M; Brunello, A; Badalamenti, G; Nannini, M; Ibrahim, T; Hohenberger, P; Gasperoni, S; Gennatas, S; Jones, RL; Hindi, N; Martin-Broto, J; Ceruso, MS; Silletta, M; Tos, APD; Gronchi, A; Stacchiotti, S; Santini, D; Tonini, G; Palassini, E; Vincenzi, B
Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis
ESMO OPEN
Constantinidou, A; Sauve, N; Stacchiotti, S; Blay, JY; Vincenzi, B; Grignani, G; Rutkowski, P; Guida, M; Hindi, N; Klein, A; Thibaud, V; Sufliarsky, J; Desar, I; Steeghs, N; Litiere, S; Gelderblom, H; Jones, RL
Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study
ESMO OPEN
Martin-Broto, J; Hindi, N; Grignani, G; Martinez-Trufero, J; Redondo, A; Valverde, C; Stacchiotti, S; Lopez-Pousa, A; D'Ambrosio, L; Gutierrez, A; Perez-Vega, H; Encinas-Tobajas, V; de Alava, E; Collini, P; Pena-Chilet, M; Dopazo, J; Carrasco-Garcia, I; Lopez-Alvarez, M; Moura, DS; Lopez-Martin, JA
Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial
JOURNAL FOR IMMUNOTHERAPY OF CANCER
Martin-Broto, J; Moura, DS; Van Tine, BA
Facts and Hopes in Immunotherapy of Soft-Tissue Sarcomas
CLINICAL CANCER RESEARCH
Serrano, C; Vivancos, A; Lopez-Pousa, A; Matito, J; Mancuso, FM; Valverde, C; Quiroga, S; Landolfi, S; Castro, S; Dopazo, C; Sebio, A; Virgili, AC; Menso, MM; Martin-Broto, J; Sanso, M; Garcia-Valverde, A; Rosell, J; Fletcher, JA; George, S; Carles, J; Arribas, J
Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors
BMC CANCER
Anderton, J; Moroz, V; Marec-Berard, P; Gaspar, N; Laurence, V; Martin-Broto, J; Sastre, A; Gelderblom, H; Owens, C; Kaiser, S; Fernandez-Pinto, M; Fenwick, N; Evans, A; Strauss, S; Whelan, J; Wheatley, K; Brennan, B
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol
TRIALS
Gronchi, A; Palmerini, E; Quagliuolo, V; Broto, JM; Pousa, AL; Grignani, G; Brunello, A; Blay, JY; Tendero, O; Diaz Beveridge, R; Ferraresi, V; Lugowska, I; Merlo, DF; Fontana, V; Marchesi, E; Braglia, L; Donati, DM; Palassini, E; Bianchi, G; Marrari, A; Morosi, C; Stacchiotti, S; Bague, S; Coindre, JM; Dei Tos, AP; Picci, P; Bruzzi, P; Casali, PG
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups
JOURNAL OF CLINICAL ONCOLOGY
Martin-Broto, J; Hindi, N; Aguiar, S; Badilla-Gonzalez, R; Castro-Oliden, V; Chacon, M; Correa-Generoso, R; de Alava, E; Donati, DM; Eriksson, M; Falla-Jimenez, M; German, G; Silva, MLG; Gouin, F; Gronchi, A; Haro-Varas, JC; Jimenez-Brenes, N; Kasper, B; de Mello, CAL; Maki, R; Martinez-Delgado, P; Martinez-Said, H; Martinez-Tlahuel, JL; Morales-Perez, JM; Munoz-Casares, FC; Nakagawa, SA; Ortiz-Cruz, EJ; Palmerini, E; Patel, S; Moura, DS; Stacchiotti, S; Sunyach, MP; Valverde, CM; Waisberg, F; Blay, JY
Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID-19 Pandemic
ONCOLOGIST
Kamposioras, K; Mauri, D; Papadimitriou, K; Anthoney, A; Hindi, N; Petricevic, B; Dambrosio, M; Valachis, A; Kountourakis, P; Kopecky, J; Kuhar, CG; Popovic, L; Chilingirova, NP; Zarkavelis, G; de Mello, RA; Plavetic, ND; Christopoulos, C; Mostert, B; Goffin, JR; Tzachanis, D; Saraireh, HH; Ma, F; Pavese, I; Tolia, M
Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth
FRONTIERS IN ONCOLOGY
Moura, DS; Sanchez-Bustos, P; Fernandez-Serra, A; Lopez-Alvarez, M; Mondaza-Hernandez, JL; Blanco-Alcaina, E; Gavilan-Naranjo, A; Martinez-Delgado, P; Lacerenza, S; Santos-Fernandez, P; Carrasco-Garcia, I; Hidalgo-Rios, S; Gutierrez, A; Ramos, R; Hindi, N; Taron, M; Lopez-Guerrero, JA; Martin-Broto, J
CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study
CANCERS
Martinez-Font, E; Perez-Capo, M; Ramos, R; Felipe, I; Garcias, C; Luna, P; Terrasa, J; Martin-Broto, J; Vogler, O; Alemany, R; Obrador-Hevia, A
Impact of Wnt/beta-Catenin Inhibition on Cell Proliferation through CDC25A Downregulation in Soft Tissue Sarcomas
CANCERS
Fernandez-Serra, A; Moura, DS; Sanchez-Izquierdo, MD; Calabuig-Farinas, S; Lopez-Alvarez, M; Martinez-Martinez, A; Carrasco-Garcia, I; Ramirez-Calvo, M; Blanco-Alcaina, E; Lopez-Reig, R; Obrador-Hevia, A; Alemany, R; Gutierrez, A; Hindi, N; Poveda, A; Lopez-Guerrero, JA; Martin-Broto, J
Prognostic Impact of let-7e MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) Study
CANCERS
Hindi, N; Garcia, IC; Sanchez-Camacho, A; Gutierrez, A; Peinado, J; Rincon, I; Benedetti, J; Sancho, P; Santos, P; Sanchez-Bustos, P; Marcilla, D; Encinas, V; Chacon, S; Munoz-Casares, C; Moura, D; Martin-Broto, J
Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center
CANCERS
Martinez-Delgado, P; Lacerenza, S; Obrador-Hevia, A; Lopez-Alvarez, M; Mondaza-Hernandez, JL; Blanco-Alcaina, E; Sanchez-Bustos, P; Hindi, N; Moura, DS; Martin-Broto, J
Cancer Stem Cells in Soft-Tissue Sarcomas
CELLS
Stacchiotti S, Ferrari S, Redondo A, Hindi-Muniz N, Palmerini E, Vaz Salgado MA, Frezza AM, Casali PG, Gutierrez A, Lopez-Pousa A, Grignani G, Italiano A, LeCesne A, Dumont S, Blay JY, Penel N, Bernabeu D, de Alava E, Karanian M, Morosi C, Brich S, Dagrada GP, Vallacchi V, Castelli C, Brenca M, Racanelli D, Maestro R, Collini P, Cruz J, Martin-Broto J.
Pazopanib for f advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial
Lancet Oncol.
Martin-Broto J, Stacchiotti S, Lopez-Pousa A, Redondo A, Bernabeu D, de Alava E, Casali PG, Italiano A, Gutierrez A, Moura DS, Peña-Chilet M, Diaz-Martin J, Biscuola M, Taron M, Collini P, Ranchere-Vince D, Garcia Del Muro X, Grignani G, Dumont S, Martinez-Trufero J, Palmerini E, Hindi N, Sebio A, Dopazo J, Dei Tos AP, LeCesne A, Blay JY, Cruz J.
Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial.
Lancet Oncol
Alemany R, Moura DS, Redondo A, Martinez-Trufero J, Calabuig S, Saus C, Obrador-Hevia A, Ramos R, Villar VH, Valverde C, Vaz MA, Medina J, Felipe-Abrio I, Hindi N, Taron M, Martin-Broto J.
Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on Sarcoma.
Clin Cancer Res.
Moura DS, Ramos R, Fernandez-Serra A, Serrano T, Cruz J, Alvarez-Alegret R, Ortiz-Duran R, Vicioso L, Gomez-Dorronsoro ML, Garcia Del Muro X, Martinez-Trufero J, Rubio-Casadevall J, Sevilla I, Lainez N, Gutierrez A, Serrano C, Lopez-Alvarez M, Hindi N, Taron M, López-Guerrero JA, Martin-Broto J.
Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients.
Oncotarget
Martin-Broto J, Redondo A, Valverde C, Vaz MA, Mora J, Garcia Del Muro X, Gutierrez A, Tous C, Carnero A, Marcilla D, Carranza A, Sancho P, Martinez-Trufero J, Diaz-Beveridge R, Cruz J, Encinas V, Taron M, Moura DS, Luna P, Hindi N, Lopez-Pousa A.
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS).
Ann Oncol
Martin-Broto J, Pousa AL, de Las Peñas R, García Del Muro X, Gutierrez A, Martinez-Trufero J, Cruz J, Alvarez R, Cubedo R, Redondo A, Maurel J, Carrasco JA, López-Martin JA, Sala Á, Meana JA, Ramos R, Martinez-Serra J, Lopez-Guerrero JA, Sevilla I, Balaña C, Vaz Á, De Juan A, Alemany R, Poveda A.J
Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study.
J Clin Oncol